Surgical Innovations Group (SUN) Share Price, News & Analysis

Company Overview

About Surgical Innovations Group plc The Group specialises in the design, manufacture, sale and distribution of innovative, high quality medical products, primarily for use in minimally invasive surgery. Our product and business development is guided and supported by a key group of nationally and internationally renowned surgeons across the spectrum of minimally invasive surgical activity. We design and manufacture and source our branded port access systems, surgical instruments and retraction devices which are sold directly in the UK home market through our subsidiary, Elemental Healthcare, and exported widely through a global network of trusted distribution partners. Many of our products in this field are based on a "resposable" concept, in which the products are part reusable, part disposable, offering a high quality and environmentally responsible solution at a cost that is competitive against fully disposable alternatives. Elemental also has exclusive UK distribution for a select group of specialist products employed in laparoscopy, bariatric and metabolic surgery, hernia repair and breast reconstruction. In addition, we design and develop medical devices for carefully selected OEM partners and have also collaborated with a major UK industrial partner to provide precision engineering solutions to complex problems outside the medical arena. We aim for our brands to be recognised and respected by healthcare professionals in all major geographical markets in which we operate and provide by development, partnership or acquisition a broad portfolio of cost effective, procedure specific surgical instruments and implantable devices that offer reliable solutions to genuine clinical needs in the operating theatre environment. Further information: Further details of the Group's businesses and products are available on the following websites: www.sigroupplc.com www.surginno.com www.elementalhealthcare.co.uk

Key Stats

• Today's Range: 0.67 to 0.70
• 50-Day Range: 0.51 to 0.73
• 52-Week Range: 0.40 to 0.98
• Volume: 1.61 million shs
• Average Volume: 1.86 million shs
• Market Capitalization: £6.25 million
• P/E Ratio: N/A
• Dividend Yield: 2.63%
• Price Target: N/A
• Consensus Rating: N/A

SUN Stock Analysis - Frequently Asked Questions

How have SUN shares performed this year?

Surgical Innovations Group's stock was trading at GBX 0.55 on January 1st, 2025. Since then, SUN stock has increased by 22.9% and is now trading at GBX 0.67.
View the best growth stocks for 2025 here.

How were Surgical Innovations Group's earnings last quarter?

Surgical Innovations Group plc (LON:SUN) announced its earnings results on Friday, May, 30th. The company reported ($0.07) earnings per share (EPS) for the quarter. Surgical Innovations Group had a negative trailing twelve-month return on equity of 6.04% and a negative net margin of 4.96%.

How do I buy shares of Surgical Innovations Group?

Shares of SUN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Surgical Innovations Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Surgical Innovations Group investors own include Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), Express (EXPR), Charles Schwab (SCHW), Accenture (ACN), Adams Diversified Equity Fund (ADX) and Xtrackers California Municipal Bond ETF (CA).

Company Calendar

• Last Earnings: 5/30/2025
• Today: 7/02/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: Petroleum And Natural Gas
• Current Symbol: LON:SUN
• CIK: N/A
• Web: www.sigroupplc.com
• Phone: +44-113-2307597
• Fax: N/A
• Employees: 80
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: -4.96%
• Pretax Margin: N/A
• Return on Equity: -6.04%
• Return on Assets: -3.03%

Debt

• Debt-to-Equity Ratio: 13.96
• Current Ratio: 1.94
• Quick Ratio: 1.61

Sales & Book Value

• Annual Sales: £12.54 million
• Price / Sales: 0.50
• Cash Flow: GBX 0.13 per share
• Price / Cash Flow: 5.03
• Book Value: GBX 1 per share
• Price / Book: 0.67

Miscellaneous

• Outstanding Shares: 932,820,000
• Free Float: N/A
• Market Cap: £6.25 million
• Optionable: Not Optionable
• Beta: 0.65